PubMed Health. A service of the National Library of Medicine, National Institutes of Health.
A.D.A.M. Medical Encyclopedia [Internet]. Atlanta (GA): A.D.A.M.; 2013.
A.D.A.M. Medical Encyclopedia.
Chlamydia is a disease caused by the bacteria Chlamydia trachomatis. It is most commonly sexually transmitted.
Causes, incidence, and risk factors
Chlamydia infection is the most common sexually transmitted disease in the United States. Sexually active individuals and individuals with multiple partners are at highest risk.
Symptoms
As many as 25% of men with chlamydia have no symptoms. In men, chlamydia may produce symptoms similar to gonorrhea. Symptoms may include:
- Burning sensation during urination
- Discharge from the penis or rectum
- Testicular tenderness or pain
- Rectal discharge or pain
About 70% of women with chlamydia have no symptoms. Symptoms that may occur in women include:
- Burning sensation during urination
- Painful sexual intercourse
- Rectal pain or discharge
See also: Chlamydia in women
Signs and tests
The diagnosis of chlamydia infection involves sampling of the urethral discharge in males or cervical secretions in females. If an individual engages in anal sexual contact, samples from the rectum may also be needed. The sample is sent for a fluorescent or monoclonal antibody test, DNA probe test, or cell culture. Some of these tests may also be performed on urine samples.
Treatment
The usual treatment for chlamydia is antibiotics, including tetracyclines, azithromycin, or erythromycin.
You can get chlamydia with gonorrhea or syphilis, so if you have one sexually transmitted disease you must be screened for other sexually transmitted diseases as well. All sexual contacts should be screened for chlamydia.
Sexual partners must be treated to prevent passing the infection back and forth. There is no significant immunity following the infection and a person may become repeatedly infected.
A follow-up evaluation may be done in 4 weeks to determine if the infection has been cured.
Expectations (prognosis)
Early antibiotic treatment is extremely successful and may prevent the development of long-term complications. Untreated infection, however, may lead to complications.
Complications
Chlamydia infections in women may lead to inflammation of the cervix. In men, chlamydia infection can lead to inflammation of the urethra called urethritis.
An untreated chlamydia infection may spread to the uterus or the fallopian tubes, causing salpingitis or pelvic inflammatory disease. These conditions can lead to infertility and increase the risk of ectopic pregnancy.
If a women is infected with chlamydia while pregnant, the infection may cause infection in the uterus after delivery (late postpartum endometritis). In addition, the infant may develop chlamydia-related conjunctivitis (eye infection) and pneumonia. See: chlamydial pneumonia
Calling your health care provider
Call your health care provider if you have symptoms of chlamydia.
Because many people with chlamydia may not have symptoms, sexually active adults should be screened periodically for the infection.
Prevention
All sexually active women up through age 25 should be screened yearly for chlamydia. All women with new sexual partners or multiple partners should also be screened.
A mutually monogamous sexual relationship with an uninfected partner is one way to avoid this infection. The proper use of condoms during intercourse usually prevents infection.
References
- U.S. Preventive Services Task Force. Screening for chlamydial infection: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2007;147:128-134. [PubMed: 17576996]
- Stamm WE, Batteiger BE. Chlamydiatrachomatis (trachoma, perinatal infections, lymphogranuloma venereum, and other genital infections). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2009:chap 180.
Review Date: 6/7/2010.
Reviewed by: Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; Susan Storck, MD, FACOG, Chief, Eastside Department of Obstetrics and Gynecology, Group Health Cooperative of Puget Sound, Redmond, Washington; Clinical Teaching Faculty, Department of Obstetrics and Gynecology, University of Washington School of Medicine. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only — they do not constitute endorsementscof those other sites. © 1997–2011 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
Topical microbicides for prevention of sexually transmitted infections
Microbicide research has had disappointing outcomes during the last two decades as most microbicides have not shown evidence that they can prevent acquisition of sexually transmitted infections (STIs), including human immunodeficiency virus (HIV). However, a recent small preliminary study suggests that microbicides containing the antiretroviral drug tenofovir may prevent acquisition of HIV and herpes simplex virus infection in women; but further research is needed to assess the generalisability of these findings. Therefore, there is not enough evidence to recommend topical microbicides for HIV or STI prevention at present.
How we know if a treatment worksTesting Treatments is a lively look at modern clinical research, and how everyone can get involved in using and improving research for better health care.
- ChlamydiaChlamydiaPubMed Health
Your browsing activity is empty.
Activity recording is turned off.
See more...